Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Chemotherapeutics like 5-fluorouracil (5-FU) may induce a variety of adverse effects, including oral mucositis (OM), which may necessitate treatment discontinuation in patients with cancer. Currently, only a few models of OM are available for studying many aspects of pathophysiology and treatments.

Aim: The current study examined the clinical and histological aspects of 5-fluorouracil-induced oral mucositis (5FU-OM) in rats.

Methods: We randomly divided 19 male Sprague-Dawley rats into 8 healthy rats and 11 that received a single dose of 5FU-OM. On the first day of the experiment, the 5FU-OM group was administered an intraperitoneal injection of 5-FU (150-mg/kg BW), whereas the healthy group was not administered the drug. The third day involved scratching the oral mucosa of all rats in both groups. Clinical observations included changes in body weight, food consumption, hair loss, and severity of oral lesions. At the end of the study, we collected cardiac blood and mucosal tissue samples to investigate hematological and histological alterations.

Results: Our findings demonstrated that a single intraperitoneal injection of 5-FU and mucosal irritation might result in ulcerative OM. We discovered other clinical toxicities caused by chemotherapy, such as weight loss, red lacrimation, facial edema, epistaxis, and hair loss. 5-FU also produced hematological abnormalities, including anemia and thrombocytopenia. Histopathological changes included ulceration, bleeding, vasodilation, edema, and inflammatory cell infiltration.

Conclusion: This simple rat model of OM accurately replicates the clinical and histological mucosal responses to chemotherapy, including its systemic adverse effects. Thus, it can be used in research on OM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184472PMC
http://dx.doi.org/10.5455/OVJ.2025.v15.i5.10DOI Listing

Publication Analysis

Top Keywords

oral mucositis
12
5-fluorouracil-induced oral
8
rat model
8
adverse effects
8
clinical histological
8
group administered
8
intraperitoneal injection
8
injection 5-fu
8
hair loss
8
clinical
5

Similar Publications

Betrixaban is a broad anti-virus inhibitor by activating innate immunity.

Front Cell Infect Microbiol

September 2025

Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, China.

The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects.

View Article and Find Full Text PDF

Objective: A cross-sectional study was made to evaluate the role of local factors, including surgical, implant, and prosthesis-related parameters, in the presence of peri-implantitis.

Methods: Consecutive partially edentulous patients with ≥ 1 implant presenting peri-implantitis were included. Clinical and radiographic data were collected to characterize local factors.

View Article and Find Full Text PDF

Objective: Cinnamon-induced contact stomatitis (CCS) is a hypersensitivity reaction associated with cinnamon-containing products (CCPs). We performed a retrospective study of 74 cases of CCS induced by chewing gums or candies and reviewed the literature.

Materials And Methods: This is a retrospective study of CCS cases, diagnosed during 2010-2025, characterised by temporal association of lesions with the consumption of cinnamon-containing chewing gums or candies; lesion's resolution after discontinuation of those CCPs; and absence of recurrence as long as those CCPs were not re-used.

View Article and Find Full Text PDF

Objective: To critically appraise and synthesise existing risk prediction models for chemotherapy-induced oral mucositis (CIOM) in cancer patients, identifying their methodological strengths, limitations, and clinical utility to guide future model refinement.

Methods: Relevant literature on CIOM risk prediction models published in PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang Data Knowledge Service Platform, VIP, and CBM was searched, covering the period from the inception of the databases to May 9, 2025. Researchers independently screened the literature and extracted data, utilising the Prediction Model Risk Of Bias Assessment Tool (PROBAST) to evaluate the quality of the models.

View Article and Find Full Text PDF

Chemotherapy-induced gastrointestinal toxicity is a significant dose-limiting complication for cancer treatment. Disruption of the gastrointestinal (GI) epithelial barrier function by several chemotherapeutic agents results in development of mucositis and diarrhea. Thus, maintaining barrier integrity may be of therapeutic benefit.

View Article and Find Full Text PDF